On February 1, 2008, the FDA issued a public health advisory regarding Chantix and announced new safety information and warnings to the labeling. The new labeling includes revisions to the WARNINGS and PRECAUTIONS sections of the prescribing information for Chantix regarding serious neuropsychiatric symptoms experienced in patients taking Chantix. Continue reading ⇒

